Medical Foods Market Size to Reach USD 32.5 Billion by 2030

According to Vision Research Report, the global Medical Foods market size was USD 20.2 Billion in 2021 and is expected to reach USD 32.5 Billion by 2030 and register a revenue CAGR of 5.1% during the forecast period, 2022-2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39141

Growth Factors

Increasing incidences of chronic diseases, the rising geriatric population, and the growing burden of malnutrition are the major factors responsible for the substantial growth of the market over the years. For instance, according to a WHO report, about 149 million children under 5 were stunted and 38.9 million were obese or overweight due to undernutrition in 2020. The emerging focus of the policymakers to manage chronic disorders and nutritional deficiency is also anticipated to drive the adoption of medical foods over the years.

The growing prevalence of communicable and non-communicable diseases and increasing effort for the dietary management of those diseases are anticipated to propel the market growth over the forecast years. For instance, as per the research data published by the University of Liege, it has been estimated that in Europe, the sarcopenia population will increase to 12.9% by 2045 from 11.1% in 2016.

Report Coverage

By Product Analysis

The powder segment accounted for the largest revenue share of over 35.0% in 2021 owing to the high commercial availability of medical foods in the form of powder. In addition, increasing preference and ease in consumption by the pediatric and geriatric patients suffering from different chronic diseases are fueling the segment growth.

The liquid segment is anticipated to grow at the fastest rate during the forecast period owing to the rising adoption of liquid formulations in the pediatric and geriatric population, where the intake of solid formulations is limited or impossible and in case of clinically diagnosed dysphagia or when oral physiology is limited.

By Application Analysis

Chemotherapy-induced diarrhea accounted for the largest revenue share of over 15.0% in 2021. Diarrheal episodes interfere with the chemotherapy process and dosage pattern. Therefore, the rising need for adopting medical foods in dietary management is expected to boost the segment growth.

Because of loss of absorptive surfaces and potential mucosal damage due to chemotherapy-related diarrhea, patients should ingest specific easy-to-digest medical food, which is expected to fuel the segment growth over the forecast years.

Diabetic neuropathy is anticipated to be the fastest-growing segment over the forecast period owing to the growing prevalence of diabetes and a rise in the number of patients that are at risk of developing some level of neuropathy.

The growing number of patients suffering from diabetic neuropathy and increasing prescription by medical professionals for medical food consumption to manage the disease are the major factors propelling the segment growth. The growing prevalence of diabetic neuropathy all over the globe is further supporting the growth of the segment.

By Sales Channel Analysis

The institutional sales channel, which includes hospitals, home care settings, and disability facilities, accounted for the largest revenue share of over 40.0% in 2021. The growing number of patient visits to the hospitals and other healthcare facilities for the diagnosis and treatment of several chronic and dietary disorders is driving the segment.

The increasing preference among the patients to consult a doctor in the hospitals for their chronic disease management will drive the segment. Moreover, the growing number of private and public healthcare institutions and the increasing chronic disease patient population across the globe will support the segment growth.

The online sales segment is anticipated to expand at the fastest rate over the forecast period. Preference for the online purchase of medical foods is rising owing to the convenience offered by this sales channel. Although medical foods are mainly consumed under medical surveillance, these are intended for long-term nutrition management, which is resulting in surging sales through e-commerce.

By Regional Analysis

North America held the largest revenue share of over 30.0%. The presence of international companies such as Abbott Laboratories and Mead Johnson & Company and the high revenue generation of these companies are driving the market.

The Asia Pacific region is anticipated to be the fastest-growing regional market over the forecast period owing to the increasing rate of cancer and diabetic patients, along with several government initiatives in the healthcare segment.

Johnson & Johnson Pte. Ltd. company, Asia Pacific hosts about 50% of new cancer cases in the world each year. Further, this report stated that the death due to cancer is estimated to increase by 36% in the Asia Pacific region by 203o, which, in turn, is expected to propel the growth of the market in this region over the coming years.

Key Players

• Nestle
• Danone
• Abbott
• Mead Johnson & Company, LLC
• Fresenius Kabi
• Targeted Medical Pharma, Inc.
• Primus Pharmaceuticals, Inc.
• Medtrition, Inc.

Market Segmentation

• By Route of Administration
  • Oral
  • Enteral
• By Product
  • Pills
  • Powder
  • Liquid
  • Others
• By Application
  • Chronic Kidney Disease
  • Minimal Hepatic Encephalopathy
  • Chemotherapy Induced Diarrhea
  • Pathogen Related Infections
  • Diabetic Neuropathy
  • ADHD
  • Depression
  • Alzheimer’s Disease
  • Nutritional Deficiency
  • Orphan diseases
    • Phenylketonuria
    • Tyrosinemia
    • Eosinophilic esophagitis
    • FPIES
    • MSUD
    • Homocystinuria
    • Others
  • Wound Healing
  • Chronic Diarrhea
  • Constipation Relief
  • Protein Booster
  • Dysphagia
  • Pain Management
  • Parkinson’s Disease
  • Epilepsy
  • Other Cancer related treatments
  • Severe protein allergy
  • Other
• By Sales Channel
  • Online Sales
  • Institutional Sales
  • Retail Sales
• Regional
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Singapore
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Click Here to View Full Report Table of Contents

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39141

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com